Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
773.830.04%
QQQ
742.990.2%
BTC/USD
85333.911.4526%
DIA
519.720.01%
GLD
400.360.5%
TLT
81.830.04%

Faeth Therapeutics Inc (FTH) Stock Price, Quote, News & History

FTHNASDAQ
Trade with Public
Trade with Public
$33.29
-1.21-3.51%
At close: Sep 21, 5:00 PM EST
$33.29
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Faeth Therapeutics (FTH) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$34.50
Close
$33.29
Volume / Avg.
379.20K / 303.16K
Day Range
$32.11 - $34.81
52 Wk Range
13.43 - 42.14
Market Cap
$858.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
4.33%
Days to Cover
3.67

Recent Faeth Therapeutics, Inc News

This Nvidia Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. AVGO receives Outperform rating with $455 PT.
Avi Kapoor

This Faeth Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Wall Street analysts changed outlook on top names. Check ratings page for upgrades, downgrades, initiations. See other analysts' views on HTFL, SKYH, FTH.
Avi Kapoor

This Plexus Analyst Turns Bullish; Here Are Top 4 Upgrades For Friday

Top Wall Street analysts upgraded IP, AXTI, REPL, and PLXS stocks with higher price targets. See what other analysts think about these stocks.
Avi Kapoor

This Crowdstrike Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed outlook on top names. See all rating changes on analyst ratings page. Analysts have positive views on FTH stock.
Avi Kapoor

This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top analysts changed outlook on top names. For all changes, see analyst ratings page. See how analysts view HOOD, FXNC, NU, FTH, FRST.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-33.86M
Investing Cash Flow (TTM)
-135.68M
Financing Cash Flow (TTM)
183.88M
Free Cash Flow (TTM)
-33.86M
Capital Expenditure (TTM)
-6.00K
Net Change in Cash (TTM)
14.35M

Analyst Trends and Forecast

2
Jun
3
Jul
3
Aug
3
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$672.31M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
4.96
Earnings Yield % (TTM)
-183.26%
Earnings Yield % (FWD)
-11.50%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.69

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
-$345.00K
Total Cash
$26.90M
Debt to Equity
0.00
Issuance of Debt (TTM)
-$345.00K
Repayment of Debt (TTM)
-$345.00K

Key Statistics

Open
$34.50
Close
$33.29
Volume / Avg.
379.20K / 303.16K
Day Range
$32.11 - $34.81
52 Wk Range
13.43 - 42.14
Market Cap
$858.17M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
45
Short Interest
4.33%
Days to Cover
3.67

About

Sector
Health Care
Industry
Biotechnology
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral co...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Faeth Therapeutics (FTH) stock?

A

You can purchase shares of Faeth Therapeutics (NASDAQ:FTH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Faeth Therapeutics (FTH) competitors?

Q

What is the forecast, or price target, for Faeth Therapeutics (FTH) stock?

A

Faeth Therapeutics has a consensus price target of $57.90.

Q

What is the current price for Faeth Therapeutics (FTH)?

A

The stock price for Faeth Therapeutics (NASDAQ: FTH) is $33.29 last updated September 21, 2026 at 4:00 PM EDT.

Q

Does Faeth Therapeutics (FTH) pay a dividend?

A

There are no upcoming dividends for Faeth Therapeutics.

Q

When is Faeth Therapeutics (NASDAQ:FTH) reporting earnings?

A

Faeth Therapeutics does not have any upcoming earnings scheduled.

Q

Is Faeth Therapeutics (FTH) going to split?

A

There is no upcoming split for Faeth Therapeutics.

Q

What sector and industry does Faeth Therapeutics (FTH) operate in?

A

Faeth Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved